Acceleron Pharma (NASDAQ:XLRN) : $0.27 million worth of transactions were on upticks in Acceleron Pharma (NASDAQ:XLRN), compared to $0.19 million on downticks. The ratio between the two was 1.44, whereas, the net money flow stood at a healthy $0.08 million on Wednesdays session. The consistent buying on upticks in the stock accounted for $0.01million worth of trades. The total money flow into the stock stood at $0.01 million. The bulls and the bears were in an equilibrium as the stock closed with a loss of -0.74%. The stock was trading at $33.64, with a drop of $0.25 over the previous days close. The stock recorded 0.54% for the week.
In an insider trading activity,The officer (SVP, CFO and Treasurer) of Acceleron Pharma Inc, Mclaughlin Kevin F sold 25,300 shares at $34 on May 23, 2016. The Insider selling transaction had a total value worth of $860,200. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing. Currently the company Insiders own 12.2% of Acceleron Pharma shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -15.15% . Institutional Investors own 78.44% of Acceleron Pharma shares. During last six month period, the net percent change held by insiders has seen a change of 15.32%.
The company shares have rallied 12.89% from its 1 Year high price. On Dec 30, 2015, the shares registered one year high at $50.86 and the one year low was seen on Aug 24, 2015. The 50-Day Moving Average price is $33.99 and the 200 Day Moving Average price is recorded at $32.29. Acceleron Pharma (NASDAQ:XLRN): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $34.40 and $33.61 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $35.22. The buying momentum continued till the end and the stock did not give up its gains. It closed at $35.00, notching a gain of 3.28% for the day. The total traded volume was 298,920 . The stock had closed at $33.89 on the previous day.
Acceleron Pharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic candidates that are based on the mechanisms that the human body uses to regulate the growth and repair of its cells and tissues. The Companys research focuses on key natural regulators of cellular growth and repair, particularly the Transforming Growth Factor-Beta (TGF-b) protein superfamily. By combining its discovery and development know-how, including its knowledge of the TGF-b superfamily, and its internal protein engineering and manufacturing capabilities, the Company has built a discovery and development platform that has generated therapeutic candidates with new mechanisms of action. The Company has four internally discovered therapeutic candidates that are in clinical trials.